Condensed Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities
Net loss	$ (2,595,173)	$ (1,200,201)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	106,133	161,537
Noncash interest expense	17,123
Recovery of bad debt		(8,400)
Share-based compensation expense	590,603	28,927
Inventory obsolescence expense	3,604	80,842
Change in fair value of derivative financial instruments	(31,831)
Changes in operating assets and liabilities:
Accounts receivable	411,999	(617,535)
Inventory	45,331	(155,759)
All other assets	(25,854)	69,092
Accounts payable	(319,483)	69,811
Accrued compensation and other liabilities	145,016	(193,343)
Deferred revenue	(64,619)	451,372
Net cash used in operating activities	(1,717,151)	(1,313,657)
Cash flows from investing activities
Purchases of property and equipment	(10,034)	(25,926)
Net cash used in investing activities	(10,034)	(25,926)
Cash flows from financing activities
Proceeds from issuance of preferred stock, net of issuance costs		1,420,543
Proceeds from issuance of convertible notes and warrants, net of issuance costs	1,388,913
Proceeds from issuance of short term notes	500,000
Proceeds from exercise of stock options and warrants	55
Deferred IPO costs	(252,715)
Payments on debt	(1,250)	(1,250)
Payments on capital lease obligations	(25,640)	(27,443)
Net cash provided by financing activities	1,609,363	1,391,850
Net (decrease) increase in cash and cash equivalents	(117,822)	52,267
Cash and cash equivalents at beginning of period	749,517	1,400,345
Cash and cash equivalents at end of period	631,695	1,452,612
Supplemental disclosure of cash flow information
Cash paid during the period for interest	6,865	13,322
Supplemental disclosure of noncash investing and financing activities:
Acquisition of equipment purchased through capital leases	76,745
Exchange of demand note for convertible debt	300,000
IPO costs deferred and unpaid	$ 218,656